San Diego-dependent Viking Therapeutics marked by itself as a significant competitor from the weight loss drug market place in February right after revealing promising details from the mid-stage trial of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when supplied as a weekly injection As well as in M